Health
Peter Van den Bossche 14 February 2006European economy | Health | International tradeOver the past week, I have been amazed, and occasionally horrified, by the media and civil society response to the EC - Biotech Products dispute currently pending before a WTO dispute settlement panel in Geneva. In this dispute about trade in GMOs between the US, Canada and Argentina (complainants) and the EC (respondent), the WTO Panel sent its preliminary conclusions to the parties on 6 February 2006. The conclusions reached by the Panel in the EC - Biotech Products dispute will not alter the system or framework within which the EU takes decisions on GMOs'. Articles, reports and statements suggesting the contrary are mistaken and were definitely much ado about little.
read more | French version | envoyer à un ami
|